References
- Plöckinger U, Rindi G, Arnold R, Eriksson B, Krenning EP, de Herder WW, Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology. 2004;80:394–424.
- Williams ED, Sandler M. The classification of carcinoid tumours. Lancet. 1963;2:238–9.
- Kloppel G, Perren A, Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann NY Acad Sci. 2004;1014:13–27.
- TNM classification of malignant tumours. International Union Against Cancer. Available at http://www.uicc.org/resources/tnm.
- Bosman F, Carneiro F, Hruban R, Theise N. editors. WHO classification of tumors of the digestive system. Lyon, France: IARC Press; 2010.
- Querleu D, Morrow CP. Classification of radical hysterectomy. Lancet Oncol. 2008;9:297–303.
- Curtis RE, Freedman DM, Ron E, Ries LAG, Hacker DG, Edwards BK, New malignancies among cancer survivors: SEER cancer registries, 1973–2000. NIH publication no. 05-5302 Bethesda, MD: National Cancer Institute; 2006.
- Habal N, Sims C, Bilchik AJ. Gastrointestinal carcinoid tumors and second primary malignancies. J Surg Oncol. 2000;75:310–16.
- Zucker KA, Longo WE, Modlin IM, Bilchik AJ, Adrian TE. Malignant diathesis from jejuno-ileal carcinoids. Am J Gastroenterol. 1989;84:182–6.
- Lauffer JM, Zhang T, Modlin IM. Review article: current status of gastrointestinal carcinoids. Aliment Pharmacol Ther. 1999;13:271–87.